Therapeutic Asset Ratings
4,361 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cabozantinib
Urethra Cancer
National Cancer Institute (NCI)
P2
B
(60)
Cabozantinib
Urinary Bladder Cancer
National Cancer Institute (NCI)
P2
B
(60)
Cabozantinib
Urinary Bladder Small Cell Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Cabozantinib
Urothelial Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Capivasertib
Endometrium Adenocarcinoma
National Cancer Institute (NCI)
P2
B
(60)
Capivasertib
Recurrent Breast Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Carboplatin
Acquired Polycythemia Vera
National Cancer Institute (NCI)
P2
B
(60)
Carboplatin
Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P2
B
(60)
Carboplatin
Essential Thrombocythemia
National Cancer Institute (NCI)
P2
B
(60)
Cediranib
Bladder Cancer
National Cancer Institute (NCI)
P2
B
(60)
Cediranib
Recurrent Hepatoblastoma
National Cancer Institute (NCI)
P2
B
(60)
Ceralasertib
Breast Cancer
National Cancer Institute (NCI)
P2
B
(60)
Ceralasertib
Breast Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Ceralasertib
Endometrial Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
Essential Thrombocythemia
National Cancer Institute (NCI)
P2
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
Minimally Invasive Lung Adenocarcinoma
National Cancer Institute (NCI)
P2
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
CIS-DIAMMINEDICHLOROPLATINUM II
Polycythemia Vera
National Cancer Institute (NCI)
P2
B
(60)
Cpx-351
Myeloproliferative Neoplasm
National Cancer Institute (NCI)
P2
B
(60)
Cyclophosphamide
Digestive System Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Cyclophosphamide
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P2
B
(60)
Cyclophosphamide
Malignant Endocrine Neoplasm
National Cancer Institute (NCI)
P2
B
(60)
CYTARABINE
Acute Myeloid Leukemia, MLL Gene Rearrangement
National Cancer Institute (NCI)
P2
B
(60)
Dabrafenib
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P2
B
(60)
Dasatinib
Lymphoma
National Cancer Institute (NCI)
P2
B
(60)
Showing 776 to 800 of 4,361 assets
Previous
Page 32 of 175
Next